Heart Failure Flashcards
Carvedilol MOA
Both Beta 1 and Alpha 1 blocker
Carvedilol Clinical Application
- Chronic HF
- Reduces mortality in moderate and severe HF
Carvedilol Toxicity
- Bronchospasm
- Bradycardia
- AV block
- Acute cardiac decompensation
Isosorbide dinitrate MOA
Release NO
Isosorbide dinitrate effects
- Venodilation
- Reduce preload and ventricular stretch
Isosorbide dinitrate clinical application
Acute and chronic heart failure
Angina
Isosorbide dinitrate toxicity
- Postural hypotension
- Tachycardia
- Headache
Isosorbide dinitrate interaction
Synergistic with phosphodiesterase type 5 inhibitors
Hydralazine MOA
Increase NO synthesis
Hydralazine effects
Reduces afterload and BP
Increases CO
Hydralazine clinical applications
- Chronic HF in African Americans
- Hydralazine + Nitrates reduces mortality
Hydralazine toxicity
- Lupus-like syndrome
- Tachycadia
- Fluid retention
Nitroprusside MOA
-Rapid, powerful vasodilation -reduces preload and afterload
Nitroprusside clinical application
- Hypertensive emergency
2. Acute cardiac decompensation
Nitroprusside toxicity
Cyanide Toxicity
Thicyanate toxicity
Digoxin MOA
- Inhibits Na+/K+ ATPase pump
- Increased intracellular Ca2+
Digoxin effects
- Increases cardiac contractility
- Increases parasympathetic outflow: slowed HR, slowed AV conduction
Digoxin clinical applications
- Chronic symptomatic HF
2. Rapid ventricular rate in A-fib
Digoxin toxicity
- GI upset: N/V/D
2. Cardiac arrhythmia
Name cardiac glycoside
Digoxin
Acute heart failure heart failure drugs
- Bipyridines
- Natriuretic peptide
- Beta-adrenoceptor agonists
Beta-adrenoceptor agonists
- Dobutamine
2. Dopamine
Dobutamine MOA
Beta-1 selective agonist
Dobutamine effects
- Increases cardiac contractility
2. Increase CO
Dobutamine clinical application
Acute decompensated HF
How is Dobutamine given?
IV only
Dopamine MOA
- Dopamine receptor agonist
2. Higher doses activate Beta and Alpha adrenoreceptors
Dopamine effects
- Increases renal blood flow
2. Higher doses increases cardiac force and BP
Dopamine clinical application
- Acute decompensated HF
2. Shock
How is Dopamine given?
IV
Milrinone MOA
- Phosphodiesterase type 3 inhibitor
- Increased levels of cAMP
Milrinone effects
- Vasodilator
- Decrease PVR
- Increase cardiac contractility
Milrinone clinical application
Acute decompensated heart failure
Milrinone toxicity
Arrhythmias
Nesiritide MOA
Activates BNP receptors
Increases cGMP
Nesiritide effects
vasodilation
diuresis
Nesiritide clinical application
Acute decompensated failure
Nesiritide toxicity
Renal damage
List a natriuretic peptide
Nesiritide
List a Bipyridine
Milrinone
Ivabradine MOA
- HCN, if current inhibitor
- Prolongs diastolic time
- Reduces HR
Ivabradine clinical applications
- Sx’s of HF that are STABLE
- Normal heart beat with a resting HR @ 70 bpm
- Taking beta-blocker @ highest dose
Overall goal of Ivabradine
Reduce risk of hospitalization for worsening HF
Ivabradine contraindications
- BP <90/50
- Acute HF
- Bradycardia arrhythmias